Literature DB >> 22214252

Complementary and alternative medical therapies for children with attention-deficit/hyperactivity disorder (ADHD).

Janice Pellow1, Elizabeth M Solomon, Candice N Barnard.   

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a commonly diagnosed childhood disorder characterized by impulsivity, inattention, and hyperactivity. ADHD affects up to 1 in 20 children in the United States. The underlying etiologies of ADHD may be heterogeneous and diverse, and many possible risk factors in the development of ADHD have been identified. Conventional treatment usually consists of behavioral accommodations and medication, with stimulant medication most commonly being prescribed. Parents concerned about the side effects and long-term use of conventional medications are increasingly seeking alternatives to pharmacologic treatment. Complementary and alternative medicine (CAM) offers parents various treatment options for this condition, including dietary modifications, nutritional supplementation, herbal medicine, and homeopathy. CAM appears to be most effective when prescribed holistically and according to each individual's characteristic symptoms. Possible etiologies and risk factors for the condition also need to be considered when developing a treatment plan. This article serves to highlight the latest research regarding the most commonly used CAM for children with ADHD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22214252

Source DB:  PubMed          Journal:  Altern Med Rev        ISSN: 1089-5159


  8 in total

1.  Mindfulness as an Adjunct to Behavior Modification for Elementary-aged Children with ADHD.

Authors:  Marcela C Ramos; Fiona L Macphee; Brittany M Merrill; Amy R Altszuler; Joseph S Raiker; Elizabeth M Gnagy; Andrew R Greiner; Justin Parent; Erika K Coles; Lisa Burger; William E Pelham
Journal:  Res Child Adolesc Psychopathol       Date:  2022-07-08

2.  The effect of Rosa canina L. and a polyherbal formulation syrup in patients with attention-deficit/hyperactivity disorder: a study protocol for a multicenter randomized controlled trial.

Authors:  Haide Golsorkhi; Mostafa Qorbani; Mohammad Kamalinejad; Saeideh Sabbaghzadegan; Mohsen Bahrami; Mohammad Vafaee-Shahi; Hadi Montazerlotfelahi; Elham Abniki; Majid Dadmehr
Journal:  Trials       Date:  2022-05-23       Impact factor: 2.728

3.  Whey Protein (Ma'aljobon) as a Complementary Therapy for Treatment of Attention-deficit/ Hyperactivity Disorder (ADHD): A Randomized Open-label Controlled Clinical Trial.

Authors:  Zeinab Mostajeran; Seyed Hamdollah Mosavat; Mostafa Najafi; Majid Emtiazy; Mohammad Hashem Hashempur
Journal:  Galen Med J       Date:  2020-08-27

4.  Phytotherapy for Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review and Meta-analysis.

Authors:  Tusheema Dutta; Uttpal Anand; Shreya Sikdar Mitra; Mimosa Ghorai; Niraj Kumar Jha; Nusratbanu K Shaikh; Mahipal S Shekhawat; Devendra Kumar Pandey; Jarosław Proćków; Abhijit Dey
Journal:  Front Pharmacol       Date:  2022-05-03       Impact factor: 5.988

5.  An Increase in Dietary Supplement Exposures Reported to US Poison Control Centers.

Authors:  Nisha Rao; Henry A Spiller; Nichole L Hodges; Thiphalak Chounthirath; Marcel J Casavant; Amrit K Kamboj; Gary A Smith
Journal:  J Med Toxicol       Date:  2017-07-24

6.  The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systematic review and network meta-analysis of randomized controlled trials.

Authors:  Ferrán Catalá-López; Brian Hutton; Amparo Núñez-Beltrán; Alain D Mayhew; Matthew J Page; Manuel Ridao; Aurelio Tobías; Miguel A Catalá; Rafael Tabarés-Seisdedos; David Moher
Journal:  Syst Rev       Date:  2015-02-27

Review 7.  Natural Product-Derived Treatments for Attention-Deficit/Hyperactivity Disorder: Safety, Efficacy, and Therapeutic Potential of Combination Therapy.

Authors:  James Ahn; Hyung Seok Ahn; Jae Hoon Cheong; Ike Dela Peña
Journal:  Neural Plast       Date:  2016-02-04       Impact factor: 3.599

Review 8.  Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder.

Authors:  Amber N Edinoff; Haseeb A Akuly; John H Wagner; Megan A Boudreaux; Leah A Kaplan; Shadman Yusuf; Elisa E Neuchat; Elyse M Cornett; Andrea G Boyer; Adam M Kaye; Alan D Kaye
Journal:  Front Psychiatry       Date:  2021-12-17       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.